pharmaphorum

FEBRUARY 28, 2022

Johnson & Johnson and the ‘big three’ US pharm wholesalers say they are close to finalising a $26 billion settlement that could allow them to finally put years of litigation over their role in fuelling the opioid crisis behind them. spike in deaths in the 12 months to April 2021 to nearly 100,000.

57

57

PQA

APRIL 19, 2024

If you have news you'd like for us to spotlight in an upcoming Five For Friday, send us an email! -- Carolyn Lockwood, RN, MSN, Director of Performance Measurement Educating Patients on Polypharmacy Polypharmacy is growing, according to the IQVIA Institute for Human Data Sciences’ Global Use of Medicines report for 2024.

Communication 52

Communication 52

pharmaphorum

JULY 21, 2021

Johnson & Johnson and the ‘big three’ US pharma wholesalers are on the brink of a $26 billion settlement deal covering thousands of lawsuits alleging their involvement in contributing to the US opioid crisis, according to press reports. New York has already agreed to its own deal, a $1.1

Packaging 52

Packaging 52

PharmaShots

FEBRUARY 13, 2023

Shots: Scilex, a majority-owned subsidiary of Sorrento Therapeutics acquires rights to Elyxyb (celecoxib oral solution), a ready-to-use oral solution for the acute treatment of migraine with/out aura in adults in the US and Canada Additionally, the acquisition expands Scilex’s non-opioid portfolio in broader acute pain indications with the addition (..)

40

40

PQA

MARCH 8, 2024

Some examples of potential clinical interventions that pharmacies can utilize are meeting patient screening needs, disease-state specific controlling, polypharmacy, therapeutic interchange, opioid counseling, and member experience touchpoints. If you have questions or would like to be involved, email us at Communications@PQAalliance.org.

Community Pharmacies 52

Community Pharmacies Specialty Pharmacies Independent Pharmacies Documentation 52

PQA

OCTOBER 7, 2022

If you have news you'd like for us to spotlight in an upcoming Five For Friday, send us an email! --Ben Shirley, CPHQ, PQA Director of Performance Measurement Improving Food and Nutrition Security Facing a fragmented healthcare system and nutrition access inequities across the U.S., Email us.

Dosage 52

Dosage Vaccines 52

STAT

MAY 16, 2023

As always, you are invited to join us, or grab a water bottle if you prefer. Federal Trade Commission is expected to file a lawsuit to block Amgen from acquiring Horizon Therapeutics, Bloomberg News writes. Pardon the cliché, but crystal clear blue skies and deliciously cool breezes are encompassing the Pharmalot campus today.

Labelling 66

Labelling 66

pharmaphorum

OCTOBER 12, 2021

Already approved to treat dyskinesias (movement disorders) caused by levodopa treatment, the US regulator backed Gocovri in February for “off” episodes, periods when drug therapies lose their efficacy. Pacira builds non-opioid pipeline, buying Flexion.

FDA 83

FDA 83

BuzzRx

DECEMBER 20, 2022

Due to the national effort to increase awareness of the opioid epidemic, opioid-induced constipation has become a well-known fact. Please continue reading to find out which commonly-used drug classes are associated with this unpleasant side effect. Constipation is a widespread condition affecting 16% of adults in the US.

Compounding 52

Compounding 52

PQA

DECEMBER 2, 2022

A greater than 60% vote in support (of member organizations voting yes or no) is required for a measure to receive PQA endorsement. We also highlight our members' insights on value-based care, access for diabetic patients and pharmacy performance measures.

Scheduling Appointments 52

Scheduling Appointments Nursing Homes Dosage Medication Delivery 52

pharmaphorum

NOVEMBER 3, 2022

The hope that nerve growth factor (NGF) inhibitors could be an alternative to opioid for pain relief has finally been extinguished with the news that Regeneron had abandoned the last drug in the class.

FDA 52

FDA 52

PQA

NOVEMBER 18, 2022

Learn more below. We also highlight our members' insights on value-based care, access for diabetic patients and pharmacy performance measures.

Nursing Homes 52

Nursing Homes Dosage 52

The Checkup by Singlecare

MARCH 30, 2023

Age restrictions bring us to Medicare drug plans. Besides muscle relaxants, treatment options include benzodiazepines , opioids , antidepressants , and NSAIDs. That’s the good news for people without insurance coverage. The insurance plan may impose restrictions such as prior authorization, quantity limits, or age limits.

Insurance 52

Insurance Insurance Coverage Dosage FDA 52

The Checkup by Singlecare

FEBRUARY 6, 2023

The good news is that there are ways to treat anxiety and insomnia. Nonmedicinal methods as well as prescription medications can be used to help reduce symptoms of anxiety and insomnia. Prescribers will consider past drug use or alcohol use and the potential for abuse and dependence before prescribing a controlled substance.

Controlled Substances 98

Controlled Substances Labelling FDA Communication 98

Pharmacy Is Right For Me

MARCH 21, 2024

I did all kinds of antibiotic stewardship and opioid stewardship consults there. A Touchdown in Compassion: From the Football Field to Patient Connection For this story, Jason takes us all the way back to 1997, when he played as a starter on the national championship team for the Michigan Wolverines. It was a really neat experience.

Hospitals 130

Hospitals Community Pharmacies Compounding 130

The Guardian - Pharmaceutical Industry

JANUARY 28, 2024

Dr Art Van Zee set out in the early 2000s to tell anyone who would listen how a powerful opioid was destroying lives. Two decades later, he’s still in disbelief When Dr Art Van Zee finally understood the scale of the disaster looming over his corner of rural Virginia, he naively imagined the drug industry would be just as alarmed.

96

96

pharmaphorum

FEBRUARY 26, 2021

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . In 1959, J&J acquired McNeil Laboratories in the US and also Cilag Chemie, AG in Europe. billion) hit the company in 2019.

Vaccines 119

Vaccines Labelling Communication 119

The Guardian - Pharmaceutical Industry

DECEMBER 17, 2022

The latest CDC guidelines have caused controversy after dropping specific limits on dosages and lengths of prescribing from a key summary of recommendations used by physicians.

Dosage 98

Dosage 98

The Thyroid Pharmacist

DECEMBER 28, 2022

The good news is that there is something you can do to combat these deficiencies. This confirms what many of us in the world of functional medicine believe to be true: you do not have to have celiac disease to benefit from a gluten-free diet. Do you have deficiencies in vitamin D, ferritin, B12, or other nutrients as well?

Immunization 108

Immunization Labelling FDA 108

The Guardian - Pharmaceutical Industry

DECEMBER 4, 2023

Under a court reorganization plan, Sackler family members who controlled the Oxycontin maker were granted immunity and did not have to declare personal bankruptcy in exchange for a $6bn settlement, paid out over 10 years, to a fund created to offset costs created by the opioid dependency crisis that has cost hundreds of thousands of lives.

Immunization 57

Immunization 57

The Guardian - Pharmaceutical Industry

MAY 30, 2023

The second US circuit court of appeals in New York determined the company can shield its owners from legal claims in exchange for a $6bn contribution to the company’s broader bankruptcy settlement, in a ruling that also cleared the way for Purdue to settle lawsuits tied to America’s devastating opioid epidemic.

74

74

The Guardian - Pharmaceutical Industry

MAY 19, 2023

University is latest body to distance itself from sponsorship by owners of Purdue Pharma, makers of OxyContin King’s College London has become one of the latest UK institutions to sever all ties with the Sackler family following outrage over its role in the deadly opioids epidemic in the US.

65

65

The Guardian - Pharmaceutical Industry

SEPTEMBER 1, 2023

V&A has faced criticism for being slow to disassociate itself from benefactors with role in US opioid epidemic The V&A Dundee has become the latest UK museum to remove a reference to the money it received from the Sackler family amid continuing anger over its central role in the opioid epidemic in the US.

70

70

The Nontraditional Pharmacist

NOVEMBER 20, 2019

But maybe let’s start there and that’s a good place for us to start is your work with medical affairs. So we have offices in the US, in Europe, Asia, Mumbai, India, as well as in South America. And, you know, in Kazakhstan, physicians don’t make the type of salary that physicians make in the US.

Communication 52

Communication 52

The Guardian - Pharmaceutical Industry

AUGUST 17, 2022

CVS, Walgreens and Walmart must pay damages to two Ohio counties for oversupplying pills that ended up on black market The US pharmacy chains CVS, Walmart and Walgreens must pay a combined $650.6m to two Ohio counties to address the damage done by the opioid epidemic, a federal judge ruled on Wednesday.

75

75

The Guardian - Pharmaceutical Industry

AUGUST 10, 2022

The pharmacy chain failed to properly investigate suspicious opioid orders, according to federal ruling Walgreens “substantially contributed” to San Francisco’s opioid epidemic by failing to perform due diligence on prescriptions that flooded into the city for 15 years, a federal judge has found. Continue reading.

91

91

The Guardian - Pharmaceutical Industry

SEPTEMBER 3, 2022

The maker of lauded films including Risk (about Wikileaks) and Citizenfour (about Edward Snowden) was premiering All the Beauty and the Bloodshed in competition at the Venice film festival on Saturday.

69

69

pharmaphorum

JULY 6, 2022

A court in West Virginia has ruled that US drug distributors McKesson, AmerisourceBergen and Cardinal Health are not responsible for fuelling the opioid crisis that has claimed thousands of lives in the state. “The opioid crisis has taken a considerable toll on the citizens of Cabell County and the City of Huntington.

Hospitals 57

Hospitals 57

pharmaphorum

JANUARY 19, 2022

million) to end their legal battle over Endo’s role in the opioid epidemic in the United States. Endo is accused of deceptive marketing of opioids, downplaying addiction risks, and failing to monitor suspicious opioid orders. The post Endo, Florida reach $65M opioid settlement appeared first on.

52

52

The Thyroid Pharmacist

SEPTEMBER 8, 2023

The body is always adapting to our environment and trying to keep us healthy and safe. I like to say that those of us with Hashimoto’s are the canaries in the coal mines, and our symptoms are the signs of the invisible dangers surrounding us. If you’ve already removed these foods from your diet, that’s great news!

Health and Personal Care Stores 93

Health and Personal Care Stores Adverse Reactions Compounding Immunization 93

The Thyroid Pharmacist

MAY 19, 2023

The autoimmune attack on the thyroid develops decades before a person becomes hypothyroid, so catching the condition early allows us to prevent its progression. Fight or flight” mode can save us from danger and help us tackle the challenging situations in life. I’ll discuss this further below. However, low doses of 1.5

Immunization 59

Immunization Insurance Compounding Insurance Coverage 59

The Guardian - Pharmaceutical Industry

AUGUST 10, 2023

The court also paused bankruptcy proceedings concerning Purdue and its affiliates and said in a brief order that it would hold oral arguments in December in the administration’s appeal of a lower court’s ruling upholding the settlement.

75

75

pharmaphorum

OCTOBER 22, 2020

After years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in the US opioid epidemic that will cost it up to $8.3 billion in civil damages to states affected by the opioid crisis, which the Department of Justice said was the largest penalties ever levied against a pharmaceutical manufacturer.

Packaging 52

Packaging 52

The FDA Law Blog

DECEMBER 14, 2023

US Health Officials Urge Moving Pot to Lower-Risk Tier, Bloomberg News (Aug. Rescheduling cannabis to schedule III, the governors asserted, would protect the public against more dangerous drug use because legal cannabis products sold in states where they are legal “are significantly safer than myriad alternatives, including opioids.”

Packaging 59

Packaging Controlled Substances Labelling Hospitals 59

pharmaphorum

FEBRUARY 15, 2022

Opponents focused on his ties to the pharma industry and concerns that he would not take a sufficiently tough stance on the opioid crisis, while some pro-life senators also said they were concerned about the FDA’s recent move to make it easier to access the abortion pill mifepristone. pic.twitter.com/rxxuwmeKzM.

FDA 52

FDA 52